https://techcrunch.com/2020/04/14/potential-new-treatment-for-covid-19-uncovered-by-benevolentai-enters-trials/

BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as a potential treatment for COVID-19, after it applied its AI platform and team to the problem. The revelation, which has now appeared in peer-reviewed scientific journals and has already entered clinical trials with a major pharmaceutical company, could offer a glimmer of hope to a world locked-down by the pandemic.

In February, BenevolentAI set up a specialist scientific team and launched an investigation using its drug discovery platform.